F.D.A. approves a new diabetes drug from J.&J

Source: Katie Thomas and Andrew Pollak - The N.Y. Times (Paid Registration)

The drug, Invokana, will be sold by Johnson & Johnson and treats patients with type 2 diabetes in a new way, by causing blood sugar to be excreted in the urine. Many existing drugs work by affecting the supply or use of insulin.

Read Full Article: F.D.A. approves a new diabetes drug from J.&J

 
 

Search

Quick Menu

Facebook FTwitter T
 

Consumer Help Desk

Advocacy